Fonte: Journal of the American College of Cardiology. Nome do evento: Annual Scientific Session and Expo (ACC). Unidade: FM
Assuntos: HOSPITALIZAÇÃO, MORTALIDADE, BETA-BLOQUEADORES
ABNT
NICOLAU, Jose C. et al. The role of oral beta blocker in a real-world population with non-ST segment elevation acute coronary syndromes. Journal of the American College of Cardiology. New York: Elsevier. Disponível em: https://doi.org/10.1016/S0735-1097(17)33495-2. Acesso em: 29 ago. 2024. , 2017APA
Nicolau, J. C., Ferrari, A., Coelho, G. M. M., Nakashima, C. A. K., Lima, V. M., Dalcoquio, T., et al. (2017). The role of oral beta blocker in a real-world population with non-ST segment elevation acute coronary syndromes. Journal of the American College of Cardiology. New York: Elsevier. doi:10.1016/S0735-1097(17)33495-2NLM
Nicolau JC, Ferrari A, Coelho GMM, Nakashima CAK, Lima VM, Dalcoquio T, Furtado R, Menezes F, Ramires J, Kalil-Filho R, Baracioli L. The role of oral beta blocker in a real-world population with non-ST segment elevation acute coronary syndromes [Internet]. Journal of the American College of Cardiology. 2017 ; 69 106.[citado 2024 ago. 29 ] Available from: https://doi.org/10.1016/S0735-1097(17)33495-2Vancouver
Nicolau JC, Ferrari A, Coelho GMM, Nakashima CAK, Lima VM, Dalcoquio T, Furtado R, Menezes F, Ramires J, Kalil-Filho R, Baracioli L. The role of oral beta blocker in a real-world population with non-ST segment elevation acute coronary syndromes [Internet]. Journal of the American College of Cardiology. 2017 ; 69 106.[citado 2024 ago. 29 ] Available from: https://doi.org/10.1016/S0735-1097(17)33495-2